These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2615042)

  • 1. Beneficial renal effects of CS-905, a novel dihydropyridine calcium blocker, in SHR.
    Oizumi K; Nishino H; Miyamoto M; Fukushige J; Fukami M; Koike H
    Jpn J Pharmacol; 1989 Dec; 51(4):501-8. PubMed ID: 2615042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.
    Oizumi K; Nishino H; Koike H; Sada T; Miyamoto M; Kimura T
    Jpn J Pharmacol; 1989 Sep; 51(1):57-64. PubMed ID: 2810942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
    Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of CS-905, a novel dihydropyridine calcium blocker, in conscious hypertensive dogs.
    Oizumi K; Miyamoto M; Koike H
    Jpn J Pharmacol; 1990 Jun; 53(2):264-6. PubMed ID: 2200921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic changes following long-term administration of CS-905, a novel dihydropyridine calcium blocker, in conscious SHR.
    Oizumi K; Nishino H; Miyake S; Shiga H; Sada T; Miyamoto M; Koike H
    Jpn J Pharmacol; 1990 Sep; 54(1):1-6. PubMed ID: 2273643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dihydropyridine Ca blockers on the renal function in nephrotic spontaneously hypertensive rat (SHR).
    Oizumi K; Miyamoto M; Koike H
    Biol Pharm Bull; 1994 Mar; 17(3):407-10. PubMed ID: 8019507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies of novel 1,4-dihydropyridine Ca antagonist CS-905. I. Measurement of partition coefficient (log P) by high performance liquid chromatography (HPLC)].
    Masumoto K; Takeyasu A; Oizumi K; Kobayashi T
    Yakugaku Zasshi; 1995 Mar; 115(3):213-20. PubMed ID: 7738779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal protective effect of efonidipine hydrochloride (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats.
    Shudo C; Masuda Y; Sugita H; Furukawa S; Hayashi K; Hirata H; Tanaka S; Tomita K
    Gen Pharmacol; 1994 Dec; 25(8):1567-75. PubMed ID: 7721030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of a dihydropyridine calcium channel blocker on renal injury in aldosterone-infused rats.
    Fan YY; Kohno M; Nakano D; Hitomi H; Nagai Y; Fujisawa Y; Lu XM; Fu H; Du J; Ohmori K; Hosomi N; Kimura S; Kiyomoto H; Nishiyama A
    J Hypertens; 2009 Sep; 27(9):1855-62. PubMed ID: 19633569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats.
    Sabbatini M; Vitaioli L; Baldoni E; Amenta F
    J Pharmacol Exp Ther; 2000 Sep; 294(3):948-54. PubMed ID: 10945845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats.
    Shokoji T; Fujisawa Y; Kiyomoto H; Rahman M; Sun GP; Fan YY; Kimura S; Kohno M; Abe Y; Nishiyama A
    Hypertens Res; 2005 Dec; 28(12):1017-23. PubMed ID: 16671342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition.
    Lei B; Nakano D; Fujisawa Y; Liu Y; Hitomi H; Kobori H; Mori H; Masaki T; Asanuma K; Tomino Y; Nishiyama A
    J Pharmacol Sci; 2012; 119(4):359-67. PubMed ID: 22863666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive activity of a new calcium channel blocker LF 2.0254, in spontaneously hypertensive rats: a comparison with nifedipine and nicardipine.
    Pruneau D; Brown NL
    Arch Int Pharmacodyn Ther; 1988; 295():109-24. PubMed ID: 2977540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effect of azelnidipine in rats.
    Kurashige T; Abe K; Furusu A; Miyazaki M; Obata Y; Xia Z; Nakazawa M; Nakazawa Y; Funakoshi S; Harada T; Koji T; Kohno S
    Biol Pharm Bull; 2008 Dec; 31(12):2237-44. PubMed ID: 19043206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity.
    Kimura Y; Hirooka Y; Sagara Y; Sunagawa K
    Clin Exp Hypertens; 2007 Jan; 29(1):13-21. PubMed ID: 17190727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
    Fujiwara K; Kanno Y; Hayashi K; Takenaka T; Saruta T
    Clin Exp Hypertens; 1998 Apr; 20(3):295-312. PubMed ID: 9605384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of apoptosis inhibitor of macrophages in a rat hypertension model with nephrosclerosis: possible mechanisms of action of olmesartan and azelnidipine.
    Uramatsu T; Nishino T; Obata Y; Sato Y; Furusu A; Koji T; Miyazaki T; Kohno S
    Biol Pharm Bull; 2013; 36(8):1271-7. PubMed ID: 23902971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs.
    Sironi G; Montagna E; Greto L; Bianchi G; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats.
    Nakamoto M; Ohya Y; Sakima A; Yamazato M; Takishita S
    Hypertens Res; 2007 Apr; 30(4):359-66. PubMed ID: 17541215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.